Some brain tumors may respond to immunotherapy

A new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *